FDA Brief

Company record

AbbVie Inc.

0 FDA warning letters since 2023 and 1 recall in the last 12 months.

Get an email the day FDA posts anything new about AbbVie Inc..

Recalls

ReportedClassFirmProduct and reason
Jun 3 Class III AbbVie Inc.
Drug
PRED MILD, prednisolone acetate ophthalmic suspension, USP, 0.12%, 10 mL, Sterile, Rx only, Allergen, Inc., an AbbVie company, North Chicago, IL 60064, Product of France, NDC 11980-174-10.
Failed Stability Specifications